Observational Health Data Sciences and Informatics

User Tools

Site Tools

Trace: • amt • data_etl • loinc • atc • cim10 • meeting_notes_2017_apr_04 • largescalepred • sus • meeting_notes_2017_jul-25 • icdo3
research:angioedema

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision		Previous revision
research:angioedema [2016/12/13 17:20] – jdukeresearch:angioedema [2017/12/14 05:54] (current) – schuemie
Line 7: Line 7:
 **Rationale:** The Food and Drug Administration (FDA) has [[http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/AdverseDrugEffects/ucm491645.htm|recently announced]] that they are evaluating the need for regulatory action regarding a potential association between exposure to the anti-seizure drug Keppra and angioedema. OHDSI seeks to support evidence generation for questions of importance to FDA and other stakeholders seeking to protect and promote the public's health. **Rationale:** The Food and Drug Administration (FDA) has [[http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/AdverseDrugEffects/ucm491645.htm|recently announced]] that they are evaluating the need for regulatory action regarding a potential association between exposure to the anti-seizure drug Keppra and angioedema. OHDSI seeks to support evidence generation for questions of importance to FDA and other stakeholders seeking to protect and promote the public's health.
  
-**Project Lead(s):** Jon Duke, Patrick Ryan, Marc Suchard, Martijn Schuemie+**Project Lead(s):** Jon Duke, Patrick Ryan, Marc Suchard, George Hripcsak, [?Adler], Christian Reich, Yuriy Khoma, Marie-Sophie Schwalm, Yonghui Hu, [Stanford- Juan?], Martijn Schuemie.
  
-**Coordinating Institution(s):** Regenstrief Institute+**Coordinating Institution(s):** Regenstrief Institute / Georgia Tech
  
-** Additional Participants (currently seeking additional collaborators):**  +**Participating Institution(s):**  Regenstrief Institute, Georgia Tech, Janssen Research and Development, Columbia University, University of California Los Angeles, University of Texas Houston, Stanford University, QuintilesIMS.
-  * George Hripcsak +
-  +
-Any interested collaborators please contact Jon Duke at [email protected] and I will be happy to add you to the collaborator list. +
  
-**Participating Institution(s):** Regenstrief Institute, Janssen Research and Development, Columbia University, University of California, Los Angeles +**Full Protocol:** [[https://github.com/OHDSI/StudyProtocols/blob/master/KeppraAngioedema/extras/KeppraandAngioedemaRiskStudyProtocolv0.5.docx?raw=true|Keppra and Angioedema Risk Protocol]]
- +
-**Full Protocol:** [[https://drive.google.com/file/d/0BzotZ5gIRvegT3Y5djBOUldzaVE/view?usp=sharing|Keppra and Angioedema Risk Protocol]]+
  
 **Initial Proposal Date:**  5/3/2016 **Initial Proposal Date:**  5/3/2016
research/angioedema.1481649610.txt.gz · Last modified: by jduke
Donate Powered by PHP Valid HTML5 Valid CSS Driven by DokuWiki